EXECUTIVE ENGAGEMENTS
POOL
462
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
92
Interactions with Platform & by Email
PARTICIPANTS
18
Unique # Participated
VALIDATIONS
7
Responses Validated*
COMPANIES
12
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
102
PAGES
158
EDITION
9
PRICE
USD 4950
CODE
MCP14356
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Rat Model estimated at US$510 Million in the year 2020, is projected to reach a revised size of US$815 Million by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Knockout, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$205.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Outbred segment is readjusted to a revised 7.2% CAGR for the next 7-year period.
The Rat Model market in the U.S. is estimated at US$150.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$142.2 Million by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.
In the global Inbred segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$54.3 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$93.6 Million by the year 2027.
SELECT PLAYERS
Biomere; Charles River Laboratories International, Inc.; Covance, Inc.; Envigo, Inc.; Genoway S.A.; Horizon Discovery Group PLC; Janvier Labs; Taconic Biosciences, Inc.; Transposagen Biopharmaceuticals, Inc.; Transviragen, Inc.
SEGMENTS
» End-Use (CROs, Academic & Research Institutes, Healthcare Companies) » Service (Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine, Other Services) » Type (Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Rat Model by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Knockout by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Knockout by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Outbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Outbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Inbred by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Inbred by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Immunodeficient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunodeficient by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunodeficient by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Conditioned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Conditioned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Conditioned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Breeding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Breeding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Re-Derivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Re-Derivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Re-Derivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Quarantine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Quarantine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Quarantine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Healthcare Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Healthcare Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Healthcare Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Rat Model by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Rat Model by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Rat Model by Type - Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Rat Model by Type - Percentage Breakdown of Value Sales for Knockout, Outbred, Inbred, Hybrid, Immunodeficient and Conditioned for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Rat Model by Service - Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Rat Model by Service - Percentage Breakdown of Value Sales for Cryopreservation, Breeding, Re-Derivation, Genetic Testing, Quarantine and Other Services for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Rat Model by End-Use - CROs, Academic & Research Institutes and Healthcare Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Rat Model by End-Use - Percentage Breakdown of Value Sales for CROs, Academic & Research Institutes and Healthcare Companies for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 12 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com